ARCUS BIOSCIENCES INC's ticker is RCUS and the CUSIP is 03969F109. A total of 183 filers reported holding ARCUS BIOSCIENCES INC in Q1 2023. The put-call ratio across all filers is 0.75 and the average weighting 0.2%.
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Invus Financial Advisors, LLC | 1,842,077 | $64,233,000 | 17.21% |
| Octagon Capital Advisors LP | 970,164 | $33,830,000 | 8.33% |
| Copernicus Capital Management, LLC | 17,000 | $593,000 | 7.18% |
| EcoR1 Capital, LLC | 5,122,359 | $178,617,000 | 6.21% |
| BVF INC/IL | 3,229,822 | $112,624,000 | 4.39% |
| PFM Health Sciences, LP | 3,431,010 | $119,639,000 | 3.52% |
| Alphabet Inc. | 4,100,475 | $142,984,000 | 3.39% |
| Boxer Capital, LLC | 2,084,883 | $72,700,000 | 2.54% |
| SECTORAL ASSET MANAGEMENT INC | 739,010 | $25,769,000 | 2.14% |
| Parkman Healthcare Partners LLC | 236,637 | $8,252,000 | 2.09% |